Japan Tobacco (2914) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Achieved record-high revenue and adjusted operating profit (AOP) in FY2024, driven by strong tobacco and processed food business performance, with the Vector Group acquisition expanding U.S. presence and contributing to profit growth and currency diversification.
Continued robust growth in both combustibles and Reduced-Risk Products (RRP), with Ploom's expansion to 24 markets and significant RRP revenue and volume increases.
Maintained a dividend payout ratio of 74.3% in 2024, with a dividend of JPY 194 per share and a similar forecast for 2025.
Business Plan 2025 targets high single-digit AOP growth at constant FX, supported by sustained investments in tobacco and RRP segments and continued pricing strategies.
Profit attributable to owners of the parent fell 3.9% to JPY 463.4 billion due to higher financial costs.
Financial highlights
FY2024 consolidated AOP at constant FX grew 7.5% year-on-year to JPY 782.7 billion, driven by tobacco and processed food businesses.
Reported revenue reached JPY 3,149.8 billion (+10.9% YoY); operating profit increased by 3.7% to JPY 697.2 billion.
Free cash flow declined by JPY 273.2 billion to JPY 170.5 billion, mainly due to Vector acquisition payments.
2025 forecast: core revenue at constant FX to rise 6.6%, AOP at constant FX up 8.4%, despite negative FX impacts.
Dividend for 2025 projected at JPY 194 per share, payout ratio of 76.5%.
Outlook and guidance
Business Plan 2025 (2025–2027) targets high single-digit average annual AOP growth at constant FX.
Tobacco business expected to drive growth via pricing, market share gains, and RRP expansion, though volume is forecast to decline 1-2% due to industry contraction.
Pharmaceutical business to recover to 2024 profit levels by end of plan period after a 2025 dip.
Processed food business aims for mid single-digit AOP growth, offsetting cost pressures.
RRP business expected to break even at brand contribution level by 2028.
Latest events from Japan Tobacco
- Strong H1 2026 results and upgraded full-year outlook, led by tobacco and RRP growth.2914
Q2 2026 - Q1 2026 delivered strong revenue and profit growth, with robust outlook and high dividend forecast.2914
Q1 2026 - Record-high profit and revenue in FY2025, with robust outlook and continued RRP expansion.2914
Q4 2025 - Record-high profit and revenue, higher guidance, and increased dividend after business divestiture.2914
Q3 2025 - Strong revenue and profit growth led to higher forecasts and dividend guidance for 2025.2914
Q2 2025 - Strong tobacco pricing and RRP growth drove higher profit and raised full-year guidance.2914
Q2 2024 - Revenue up 11% and US market share expanded via Vector, but profit faces cost and litigation risks.2914
Q3 2024 - Q1 2025 saw robust profit growth, pharma divestment to Shionogi, and steady dividend guidance.2914
Q1 2025